• About
    • The Forum Team
    • Public Meetings
      • Current Meetings
      • Past Meetings
    • Policy Series
      • Current Projects
        • Hepatitis B Elimination
      • Completed Projects
        • 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care
        • 2012 National Summit on HIV and Viral Hepatitis
    • Employment Opportunities
    • Internships and Fellowships
    • Achievements
    • Join our Email Service
    • Awards
      • Global Health Catalyst
      • C. Everett Koop Public Health Leadership Award
      • John G. Bartlett Award for Catalyzing Clinical Research to Improve Global Health
    • News
      • Upcoming Events
      • Forum Press Releases
      • Announcements
      • Interviews
      • Archive
    • Completed Projects
      • HCV Forum
        • HCV Forum Overview
        • Sponsors
        • Working Groups
        • Meetings
        • HCV Drug Resistance Slide Set
        • HCV Drug Resistance Mutations
        • Additional Projects of the HCV Forum
  • HBV & HDV
    • HBV & HDV Forum Overview
    • Steering Committee
    • Meetings
    • Publications
    • Sponsors
  • HIV
    • HIV Prevention
      • Overview
      • Steering Committee
      • Meetings
    • HIV Treatment and Cure
      • Overview
      • Planning Groups and Scientific Advisory Committees
      • Meetings
    • Publications
    • Archive
    • Sponsors
  • Liver
    • Liver Forum Overview
    • Steering Committee
    • ACLF
    • Pediatric Cholestatic Disease Program
    • Meetings
      • Meetings
      • Related Meetings
    • Publications
    • Sponsors
  • PSC
    • PSC Forum Overview
    • Steering Committee
    • Meetings
    • Databases/Registries
    • Sponsors
  • Rare
    • Rare Diseases Forum Overview
    • Meetings
    • Sponsors
  • TAVI
    • TAVI Forum Overview
    • Steering Committee
    • Meetings
    • Publications
    • Sponsors
  • Ocular
    • Ocular Diseases Forum Overview
    • Steering Committee
    • Meetings
    • Sponsors
  • Data & Analysis Center
    • Data Center Overview
    • Projects
      • MASH Placebo Arm Project
  • Education
    • PBHLTH 236 - U.S. Food and Drug Administration, Drug Development, Public Health And Health Policy
    • PBHLTH 266E - DIAGNOSTICS IN INFECTIOUS DISEASES: DEVELOPMENT, REGULATORY AND IMPLEMENTATION CHALLENGES
  • Publications
    • Recent Publications
    • Annals of the Forum
The Forum For Collaborative Research Logo
Newsletter Signup

Announcements

EASL & HIV in Europe Press Release: New Consensus Definition of Late Presentation for Viral Hepatitis

E-mail Print

The number of people living with viral hepatitis is increasing – a better understanding of the testing policies and strategies is needed.

Thursday, 22 October 2015, Barcelona: Today, EASL and HIV in Europe announce a consensus definition of late presentation for viral hepatitis. The announcement coincides with the European AIDS Conference in Barcelona and aims to encourage policy makers, health professionals, public health institutions and civil society organisations to implement this definition to improve the European surveillance of and response to the viral hepatitis epidemic.

Read more »
 

Publication-Hepatitis C Virus Drug Resistance-associated Substitutions: State of the Art Summary

E-mail Print
Forum staff and scientific experts on behalf of the Drug Resistance Working Group of the Forum for Collaborative HIV Research's HCV Drug Development Advisory Group (HCV DrAG) provide a comprehensive, systematic review of all resistance information available from sponsors' trials as a tool to inform the HCV drug development field. The report is now available as early view with DOI citation. Click here to read the report.
 

National HIV/AIDS Strategy: Updated to 2020

E-mail Print
on July 31, 2015

On July 30, 2015, The White House Office of AIDS Policy convened in Atlanta, GA to unveil the National HIV/AIDS Strategy, updated to 2020 after President Obama signed an executive order to mark the official release. Major changes to the NHAS include an expanded prevention toolkit, the role of The Affordable Care Act, new recommendations for HIV testing and treatment, improving the HIV Care Continuum, and using innovative research to discover new methods and tools. Click here to read the Updated National HIV/AIDS Strategy. 

 

 

In Memorium: Bob Munk

E-mail Print

Missing from The 2015 International AIDS Society Conference earlier this week, was Bob Munk, a long time friend, colleague, and AIDS activist who passed away earlier this month. His valuable and lifelong contribution to the AIDS effort in the US will never be forgotten.  

Click here to view a tribute to Bob Munk.

 

Innovation Countdown 2030 Inaugural Report, Reimagining Global Health

E-mail Print
Today, PATH launched the the Innovation Countdown 2030 (IC2030) inaugural report, Reimagining Global Health, which features 30 lifesaving innovations and thought pieces by 11 prominent thinkers. The report was officially announced at the Financing for Development conference in Addis Ababa, Ethiopia at a special side-event co-hosted by Every Women, Every Child, the Bill & Melinda Gates Foundation, the Government of Norway, PATH, UN Foundation, and Grand Challenges Canada. The report is now available for download at www.IC2030.org.
 

HIV/AIDS Qualifies as "Chronic Condition" Under ACA, Scoring Major Victory in Fight Against HIV/AIDS

E-mail Print
NOV-29-12  Press Release: On the eve of World AIDS Day, the Obama administration announced that HIV/AIDS will be one of the chronic conditions eligible for enhanced federal reimbursements through Medicaid (San Francisco AIDS Foundation).
Read more »
 

FDA and Partners Recommend Action to Reduce Viral Hepatitis Risk Among Health Care Personnel

E-mail Print
MAY-31-12  Yesterday, members of the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH), and the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) advanced one of the important action items detailed in the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.  Read more.
 
  • «
  •  Start 
  •  Prev 
  •  11 
  •  12 
  •  13 
  •  Next 
  •  End 
  • »
Page 13 of 13
 
  • The Forum Team
  • Public Meetings
    • Current Meetings
    • Past Meetings
  • Policy Series
    • Current Projects
    • Completed Projects
  • Employment Opportunities
  • Internships and Fellowships
  • Achievements
  • Join our Email Service
  • Awards
    • Global Health Catalyst
    • C. Everett Koop Public Health Leadership Award
    • John G. Bartlett Award for Catalyzing Clinical Research to Improve Global Health
  • News
    • Upcoming Events
    • Forum Press Releases
    • Announcements
    • Interviews
    • Archive
  • Completed Projects
    • HCV Forum

News

  • HBV & HDV Forum Publication Examines Benefit-Risk Considerations of Immunotherapy in Chronic Hepatitis B
    September 20, 2026
  • Improved Survival of Patients with Alagille Syndrome and Native Liver into Adolescence: An Interview with Dominika Wojdyla about EASL 2026
    August 27, 2026
  • Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group
    July 10, 2026

Events

  • Liver Forum 21
    September 09, 2026
    Read more »
  • Advances in HIV post-exposure prophylaxis (PEP): Regulatory challenges and clinical trial designs
    July 08, 2026
  • HBV Forum 16
    May 26, 2026
    Read more »
 
The Forum for Collaborative Research
1608 Rhode Island Avenue NW, Suite 212 
Washington, DC 20036

Email: [email protected]

forum logo 2024 1

ucb sph logo 2024 vertical no endorser transparent

 

Copyright © 2026 The Forum for Collaborative Research. All Rights Reserved.

Powered by Non-Profit Soapbox